Metro Healthcare Indonesia Tbk. vs Diagnos Laboratorium Utama Tbk. — how do they compare? Metro Healthcare Indonesia Tbk. trades at Rp428 (market cap 14.23T, 346.3K 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume). The key difference: Metro Healthcare Indonesia Tbk. is far larger — about 45.8× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 346.3K). Which is the better fit depends on your goals.
| CARE | DGNS | |
|---|---|---|
Market Cap | 14.23T | 310.75B |
Volume | 346.3K | 963.6K |
Lot | 3.46K | 9.64K |
Turnover | 147.93M | 217.67M |
Average Price | 427.18 | 225.89 |
Value | 147.93M | 217.67M |
Indicative Equilibrium Price | 428 | 226 |
Indicative Equilibrium Volume | 10 | 1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Metro Healthcare Indonesia Tbk (the “Company”) was established under the name PT Aruna Anjaya Perkasa, based on Notarial Deed No. 67 dated October 07, 2015 of Humberg Lie, S.H., S.E., M.Kn notary in Jakarta. The Company started its commercial operations in 2016 .
Read more on CARE →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →